The groundbreaking approach of this peptide represents a significant development in the management of type 2 diabetes. Different to existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and GIP – https://tirzepatide-peptide965947.blogsvila.com/42350379/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment